Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

BERYL DRUGS vs ERIS LIFESCIENCES - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    BERYL DRUGS ERIS LIFESCIENCES BERYL DRUGS/
ERIS LIFESCIENCES
 
P/E (TTM) x 51.6 50.9 101.4% View Chart
P/BV x 1.9 7.2 26.9% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 BERYL DRUGS   ERIS LIFESCIENCES
EQUITY SHARE DATA
    BERYL DRUGS
Mar-24
ERIS LIFESCIENCES
Mar-24
BERYL DRUGS/
ERIS LIFESCIENCES
5-Yr Chart
Click to enlarge
High Rs45971 4.6%   
Low Rs12565 2.1%   
Sales per share (Unadj.) Rs52.7147.7 35.7%  
Earnings per share (Unadj.) Rs1.529.2 5.2%  
Cash flow per share (Unadj.) Rs3.942.6 9.1%  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00-  
Book value per share (Unadj.) Rs17.6189.7 9.3%  
Shares outstanding (eoy) m5.07136.03 3.7%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x0.55.2 10.3%   
Avg P/E ratio x18.726.3 71.0%  
P/CF ratio (eoy) x7.318.0 40.5%  
Price / Book Value ratio x1.64.0 39.8%  
Dividend payout %00-   
Avg Mkt Cap Rs m144104,470 0.1%   
No. of employees `000NANA-   
Total wages/salary Rs m174,038 0.4%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m26720,091 1.3%  
Other income Rs m5238 2.0%   
Total revenues Rs m27220,330 1.3%   
Gross profit Rs m226,748 0.3%  
Depreciation Rs m121,826 0.7%   
Interest Rs m5848 0.6%   
Profit before tax Rs m104,312 0.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2342 0.7%   
Profit after tax Rs m83,971 0.2%  
Gross profit margin %8.233.6 24.5%  
Effective tax rate %23.97.9 301.1%   
Net profit margin %2.919.8 14.5%  
BALANCE SHEET DATA
Current assets Rs m10523,790 0.4%   
Current liabilities Rs m6126,090 0.2%   
Net working cap to sales %16.7-11.4 -146.0%  
Current ratio x1.70.9 190.3%  
Inventory Days Days1417 80.8%  
Debtors Days Days1,03677 1,350.7%  
Net fixed assets Rs m7244,398 0.2%   
Share capital Rs m51136 37.4%   
"Free" reserves Rs m3825,675 0.1%   
Net worth Rs m8925,811 0.3%   
Long term debt Rs m246,545 0.4%   
Total assets Rs m17768,188 0.3%  
Interest coverage x3.16.1 51.4%   
Debt to equity ratio x0.30.3 106.2%  
Sales to assets ratio x1.50.3 512.4%   
Return on assets %7.07.1 99.3%  
Return on equity %8.615.4 56.0%  
Return on capital %13.115.9 82.1%  
Exports to sales %00-   
Imports to sales %00.1 0.0%   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNA23 0.0%   
Fx inflow Rs m00-   
Fx outflow Rs m023 0.0%   
Net fx Rs m0-23 -0.0%   
CASH FLOW
From Operations Rs m84,860 0.2%  
From Investments Rs m-11-18,545 0.1%  
From Financial Activity Rs m113,798 0.0%  
Net Cashflow Rs m-2382 -0.4%  

Share Holding

Indian Promoters % 26.4 54.9 48.1%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 26.6 -  
FIIs % 0.0 8.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 73.6 45.1 163.1%  
Shareholders   7,364 46,346 15.9%  
Pledged promoter(s) holding % 0.0 18.5 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare BERYL DRUGS With:   DIVIS LABORATORIES    SUN PHARMA    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on BERYL DRUGS vs ERIS LIFESCIENCES

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

BERYL DRUGS vs ERIS LIFESCIENCES Share Price Performance

Period BERYL DRUGS ERIS LIFESCIENCES S&P BSE HEALTHCARE
1-Day 5.88% 0.46% 0.69%
1-Month -2.29% 7.54% -0.78%
1-Year 72.73% 44.85% 42.85%
3-Year CAGR 48.80% 22.64% 20.14%
5-Year CAGR 46.14% 27.07% 26.11%

* Compound Annual Growth Rate

Here are more details on the BERYL DRUGS share price and the ERIS LIFESCIENCES share price.

Moving on to shareholding structures...

The promoters of BERYL DRUGS hold a 26.4% stake in the company. In case of ERIS LIFESCIENCES the stake stands at 54.9%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of BERYL DRUGS and the shareholding pattern of ERIS LIFESCIENCES.

Finally, a word on dividends...

In the most recent financial year, BERYL DRUGS paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of 0.0%.

ERIS LIFESCIENCES paid Rs 0.0, and its dividend payout ratio stood at 0.0%.

You may visit here to review the dividend history of BERYL DRUGS, and the dividend history of ERIS LIFESCIENCES.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Trades Higher | Nifty Above 23,450 | Info Edge & SJVN Jump 5% Sensex Today Trades Higher | Nifty Above 23,450 | Info Edge & SJVN Jump 5%(10:30 am)

Asian markets traded higher on Friday, following the overnight rally on Wall Street, and the release of economic data in the region.